Angina of the kidney and the heart: the presence and prognostic impact of albuminuria in light of modern guideline-directed medical therapy in heart failure with reduced ejection fraction
Event: ESC Congress 2025
Topic: Comorbidities
Session: Acute heart failure: diagnosis, monitoring, and treatment
The development and long-term maintenance of heart failure with improved ejection fraction after a heart failure hospitalization: how are mortality rates affected?
Event: ESC Congress 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Ejection fraction in heart failure: epidemiology, comorbidity, and quality of life
The implementation of modern guideline-directed medical therapy among hospitalized patients with heart failure with reduced ejection fraction: real-world experience from two tertiary cardiac centers
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Optimal framework for heart-failure care
The eligibility of patients hospitalized for heart failure for rapid up-titration of guideline-directed medical therapy in the light of the STRONG-HF trial and the latest ESC heart failure guidelines
Event: Heart Failure 2024
Topic: Pharmacotherapy
Session: ePosters in chronic heart failure - pharmacotherapy 4
The incidence of severe heart failure among hospitalized patients with HFrEF. Do we have a simplified diagnostic criteria helping in the earlier diagnosis and better prognosis?
Event: Heart Failure 2024
Topic: Epidemiology, Prognosis, Outcome
Session: ePosters in chronic heart failure - epidemiology, prognosis, outcome 5
